Dimercaprol

CHEMBL1597 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
124.2 g/mol
LogP
0.2
Phase
4

A chelating agent, also known as BAL (British Anti-Lewisite), developed during World War II as an antidote to arsenic-containing chemical warfare agents. It is now used to treat poisoning with arsenic, mercury, and gold by binding to these metals and allowing their excretion. It must be given by painful intramuscular injection and itself carries significant toxicity.

الوزن الجزيئي

124,2300 g/mol

LogP

0,20

TPSA

22,20 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

آلية العمل

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

OCC(S)CS

InChI

InChI=1S/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H2

Molecular Formula

C3H8OS2

HBD / HBA

3 / 3

الروابط القابلة للدوران

2

الذرات الثقيلة

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A chelating agent, also known as BAL (British Anti-Lewisite), developed during World War II as an antidote to arsenic-containing chemical warfare agents. It is now used to treat poisoning with arsenic, mercury, and gold by binding to these metals and allowing their excretion. It must be given by painful intramuscular injection and itself carries significant toxicity.

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Yes, Dimercaprol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1597. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3080. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.